Article · 29 Mar 2025
Research articlePublished 9 May 2019
Hepatitis C virus (HCV): ever in reliable partnerships?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hepatitis C virus (HCV) is a parenterally transmitted hepatotropic pathogen. HCV infection is a major health problem worldwide, frequently causing cirrhosis and liver cancer. There is no preventive vaccine against HCV and treatment, consisting of interferon alpha plus Ribavirin, is generally effective in less than 50% of cases. HCV has evolved mechanisms for surviving in the host. Infection with multiple different HCV variants, as well as interaction with concurrent pathogens, might be successful strategies for viral persistence. The present review illustrates the current status of HCV co- infection with highly relevant pathogens. Issues regarding tropism, disease progression and antiviral treatment response, among other aspects, are discussed. Data accumulated reveal that HCV co-infection should not be considered the mere sum of several independent infections. Some significant questions are still unanswered. Therefore, nowadays, it might be more reasonable to face HCV co-infections as a new biological, clinical and even predominant epidemiological entity.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in African Journal of Virology Research.
Editorial · 15 Mar 2022
Functionalities of recombinant virus
Editorial · 26 Oct 2021
Virus quantification : Plaque Assay
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAfrican Journal of Virology Research
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Amador-Cañizares Yalena”
- BylineArticles whose byline prints “Dueñas-Carrera Santiago”
